Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
Two hundred patients with rheumatoid arthritis were studied in a prospective open trial comparing treatment with sulphasalazine and auranofin in patients with active disease over 12 months. The two drugs improved many parameters of disease activity at 12, 24, and 48 weeks. At 12 weeks, the group tre...
שמור ב:
| הוצא לאור ב: | Ann Rheum Dis |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
1992
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004691/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1350192/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.51.4.461 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|